Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Therapeutic Efficacy and Safety of Umbilical Cord Derived Mesenchymal Stem Cells (UMSCs) for the Management of Retinitis Pigmentosa (RP)

NCT04763369 is registered in ClinicalTrials.gov with Jinnah Burn and Reconstructive Surgery Centre, Lahore as lead sponsor.

NCT NCT04763369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04763369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Therapeutic Efficacy and Safety of Umbilical Cord Derived Mesenchymal Stem Cells (UMSCs) for the Management of Retinitis Pigmentosa (RP)
Lead sponsor
Jinnah Burn and Reconstructive Surgery Centre, Lahore
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2021
Completion date
June 30, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa (rp)